Results 221 to 230 of about 540,232 (408)

Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome [PDF]

, 2001
W. Garrett Nichols, Lawrence Corey, Ted Gooley, Chris Davis, Michael Boeckh   +4 more
openalex   +1 more source

Patient‐derived xenograft models in pan‐cancer: From bench to clinic

Interdisciplinary Medicine, EarlyView.
Abstract Patient‐derived xenograft (PDX) models provide a robust preclinical platform that preserves the genetic and phenotypic heterogeneity of patient tumors while mirroring their tumor genetic characteristics, which retain malignant cells and the tumor pathological structure, making them valuable for studying tumor progression and developing ...
Jiatong Li, Ao Gu, Nannan Tang, Gokhan Zengin, Meng‐Yao Li, Yingbin Liu   +5 more
wiley   +1 more source

Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice

Science Translational Medicine, 2016
Y. Shono, Melissa Docampo, J. Peled, S. M. Perobelli, E. Velardi, J. Tsai, Ann E. Slingerland, O. Smith, L. Young, J. Gupta, Sophia R Lieberman, Hillary V. Jay, Katya Ahr, Kori A. Porosnicu Rodriguez, Ke Xu, Marco Calarfiore, Hendrik Poeck, S. Caballero, S. Devlin, Franck Rapaport, J. Dudakov, A. Hanash, B. Gyurkocza, G. Murphy, C. Gomes, Chen Liu, Eli Moss, S. Falconer, A. Bhatt, Y. Taur, E. Pamer, M. V. D. van den Brink, R. Jenq   +32 more
semanticscholar   +1 more source

Autologous hematopoietic stem cell transplantation for mantle cell lymphoma

, 2000
Julie M. Vose, Philip J. Bierman, Dennis D. Weisenburger, James C. Lynch, Gregory Bociek, Wing C. Chan, Timothy C. Greiner, Jamés O. Armitage   +7 more
openalex   +1 more source

LncRNA IRAIN overcomes imatinib resistance in chronic myeloid leukemia via NF-κB/CD44 pathway inhibition

iScience
Summary: The development of tyrosine kinase inhibitors (TKIs) has revolutionarily increased the overall survival of patients with chronic myeloid leukemia (CML). However, drug resistance remains a major obstacle.
Xijia Wang, Yutong Hou, Yizhu Lyu, Jiayin Zhou, Xin Zhang, Mohammad Arian Hassani, Dan Huang, Zhijia Zhao, Dong Zhou, Fang Xie, Xuehong Zhang, Jinsong Yan   +11 more
doaj  

PB1969: PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND CORONAVIRUS DISEASE 2019 IN THE OMICRON ERA

HemaSphere, 2023
Feiyang Qi, Mei Bao, Xiaoshuai Zhang, Shasha Zhao, Wenwen LI, Chenglei Wang, Qian Jiang   +6 more
doaj   +1 more source

Table of contents, abbreviations, and contributors for the Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients

, 2000

openalex   +1 more source

Bone density loss after allogeneic hematopoietic stem cell transplantation: A prospective study [PDF]

, 2001
Jean M. Stern, Keith M. Sullivan, Susan M. Ott, Kristy Seidel, Jeffrey C. Fink, Gary Longton, Donald J. Sherrard   +6 more
openalex   +1 more source

A Systematic Review of the Variability of Ventilation Defect Percent Generated From Hyperpolarized Noble Gas Pulmonary Magnetic Resonance Imaging

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Hyperpolarized (HP) gas pulmonary MR ventilation images are typically quantified using ventilation defect percent (VDP); however, the test‐retest variability of VDP has not been systematically established in multi‐center trials. Herein, we perform a systematic review of the test‐retest literature on the variability of VDP, and similar metrics,
Vanessa M. Diamond, Laura C. Bell, Jeffrey N. Bone, Bastiaan Driehuys, Martha Menchaca, Giles Santyr, Sarah Svenningsen, Robert P. Thomen, Helen Marshall, Laurie J. Smith, Guilhem J. Collier, Jim M. Wild, Jason C. Woods, Sean B. Fain, Rachel L. Eddy, Jonathan H. Rayment   +15 more
wiley   +1 more source

Technique considerations for implementing volumetric‐modulated arc therapy for total body irradiation within an Australian tertiary institution

Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 165-172, March 2025.
In 2020, our institution transitioned to the Eclipse™ treatment planning system and to Truebeam® linear accelerators with 6 MV and 10 MV energies. The linear accelerators were installed in smaller bunkers that could not accommodate 400 cm FAD. A multidisciplinary team within the institution was created to evaluate existing total body irradiation ...
Gabriella La Macchia, Clare Wan, Joshua Dass, Mandy Taylor, Gabor Neveri, Malgorzata Skorska   +5 more
wiley   +1 more source